Results 191 to 200 of about 48,159 (229)

Longitudinal Assessment of the Juvenile Systemic Sclerosis Severity Score: Application in the National Registry for Childhood Onset Scleroderma

ACR Open Rheumatology, Volume 8, Issue 3, March 2026.
Objective Juvenile‐onset systemic sclerosis (jSSc) is a rare, heterogeneous pediatric autoimmune disease. Existing severity tools are often adapted from adult systemic sclerosis and lack pediatric‐specific validation. The Juvenile Systemic Sclerosis Severity Score (J4S) was developed to address this gap by capturing multiorgan disease burden.
Samantha A. Branton, Kathryn S. Torok
wiley   +1 more source

Telitacicept versus mycophenolate mofetil in IgA nephropathy: a real-world comparative study of efficacy, renal outcomes and safety. [PDF]

Clin Kidney J
He Y, Chen S, Liu K, Wu X, Yu M, Wang W, Peng K, Wang L, Li G, Xie X, Qin W, Zhong X.   +11 more
europepmc   +1 more source

Drug-induced liver injury due to avacopan improved by mycophenolate mofetil: A case report. [PDF]

Medicine (Baltimore)
Yamashita R, Izumi Y, Takane K, Kinoshita A, Hiramoto J.   +4 more
europepmc   +1 more source

A Novel Modified Bu/Vp16/cy/Flu/Ara‐C Conditioning Regimen Enhances Outcomes for High‐Risk Acute Lymphoblastic Leukemia Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Cancer Medicine, Volume 15, Issue 3, March 2026.
ABSTRACT Purpose Allogeneic hematopoietic stem cell transplantation (allo‐HSCT) effectively treats high‐risk acute lymphoblastic leukemia (ALL), yet challenges persist due to post‐transplant relapse and conditioning regimen toxicities. The determination of an appropriate preconditioning regimen is critical to improving patient outcomes.
Xiaoyan Zhao, Yifan Yao, Yan Sun, Ziwei Xu, Aiguo Liu, Xin Dong, Huafang Wang   +6 more
wiley   +1 more source

Treatment of Nephrotic Syndrome With Antinephrin Antibodies Using Plasmapheresis, Rituximab, and Mycophenolate Mofetil. [PDF]

Kidney Int Rep
Takizawa K, Shirai Y, Kajiho Y, Kanda S, Kato M, Abe H, Miura K, Hattori M, Harita Y.   +8 more
europepmc   +1 more source

Hypereosinophilia Associated With Antisynthetase Syndrome With Anti‐Ro52/PL12 Co‐Positivity: An Unusual Presentation

Clinical Case Reports, Volume 14, Issue 3, March 2026.
ABSTRACT Hypereosinophilia is uncommon in ASS and this presentation makes diagnosis more challenging. Anti‐PL12's role in the severity of ILD is controversial but its association with anti‐Ro52 seems to give a more serious disease phenotype. African ethnicity could be a negative prognostic factor, associated with lung disease severity.
Abeline Kapuczinski, Marc Léon, Camelia Rossi, Benjamin Bondue, Nathalie Demeulenaere   +4 more
wiley   +1 more source

From Thrombolysis to Transplant: Navigating the Storm of Delayed STEMI and Cardiogenic Shock

Clinical Case Reports, Volume 14, Issue 3, March 2026.
ABSTRACT Delayed STEMI presentation can cause extensive myocardial necrosis, left ventricular thrombus, cardiogenic shock, and progression to end‐stage heart failure despite reperfusion. Early recognition and timely transfer to specialized shock centers are critical.
Syed Rafay Hussain Zaidi, Muhammad Sheraz Hameed, Muhammad Ahsan, Hamza Ishfaq, Ali Iqbal, Azka Mirza, Sadia Rekhum, Muhammad Sohaib Alvi, Muhammad Usama Naveed   +8 more
wiley   +1 more source

Prescription Patterns of Mycophenolate Mofetil in a Group of Patients from Colombia. [PDF]

Healthcare (Basel)
Machado-Duque ME, Gaviria-Mendoza A, Valladales-Restrepo LF, Vallejos-Narváez Á, Piragauta-Vargas N, Machado-Alba JE.   +5 more
europepmc   +1 more source